본문으로 바로가기

News&Welfare

Photo News

Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem

  • Regdate2026-07-24 17:33
  • Hit1607
Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem 사진1
Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem 사진2
Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem 사진3
Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem 사진4
Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem 사진5
Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem 사진1
Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem 사진2
Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem 사진3
Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem 사진4
Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem 사진5

Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem


- MOHW and Novartis sign an MOU on cooperation in radioligand therapy

- Strengthening strategic collaboration to improve patient access to RLT


The MOHW (Minister Jeong Eun Kyeong) and Novartis, a global pharmaceutical company represented by Judith Love, President of Asia Pacific, Middle East and Africa (APMA), signed the MOU on July 21, 2026, at Novotel Ambassador Seoul Yongsan to support the development of an RLT ecosystem in Korea.

Attach
  • Attach Novartis to Invest KRW 140 Billion in Korea’s Radioligand Therapy Ecosystem.zip Download